RobertBruceBrackenMD
Urology • Cincinnati, OHProfessor, Surgery, University of Cincinnati College of Medicine
Dr. Bracken is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
222 Piedmont Ave
Cincinnati, OH 45219Phone+1 513-475-8787Fax+1 513-475-7348
Education & Training
New York Presbyterian Hospital (Cornell Campus)Residency, Urology, 1973 - 1974
University of MichiganResidency, Urology, 1970 - 1973
University of ManitobaClass of 1966
Certifications & Licensure
OH State Medical License 1981 - 2025
FL State Medical License 2018 - 2020
TX State Medical License 1974 - 1989- American Board of Urology Urology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
- Top MD Consumers Checkbook
Publications & Presentations
PubMed
- 28 citationsSecretory phospholipase A2-IIa is a target gene of the HER/HER2-elicited pathway and a potential plasma biomarker for poor prognosis of prostate cancer†Leslie Oleksowicz, Yin Liu, R. Bruce Bracken, Krishnanath Gaitonde, Barbara Burke
The Prostate. 2012-07-01 - 94 citationsUrinary Bladder Cancer: Role of MR ImagingSadhna Verma, Arumugam Rajesh, Srinivasa R. Prasad, Krishnanath Gaitonde, Chandana Lall
Radiographics. 2012-03-05 - 62 citationsSecretory phospholipase A2-IIa is involved in prostate cancer progression and may potentially serve as a biomarker for prostate cancerZhongyun Dong, Yin Liu, Kieran F. Scott, Linda Levin, Krishnanath Gaitonde
Carcinogenesis. 2010-11-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
